logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

The concept of weight loss pills continues to rise, Changshan Pharmaceutical's "20cm" limit up

date
11/07/2025
The concept of weight loss drugs continues to rise, Changshan Pharmaceutical's "20cm" limit up, Kaleen, Medisei, Jinkai Life Science, Borui Pharmaceutical, Norit Bio, Nanwei Technology and others follow the trend.
Latest
1 m ago
Chengdu Zhengchuan Co., Ltd.: It is expected that the net profit for the first half of 2025 will decrease by 66.20% to 77.47% compared to the same period.
2 m ago
SELON Industrial: It is expected that the net profit in the first half of the year will increase by 618.59% - 832.22% year-on-year.
2 m ago
IEA raises global crude oil supply forecast, questions Russia's production capacity.
3 m ago
Jilin Aodong: It is expected that the net profit will increase by 130.00%-140.00% in the first half of 2025.
3 m ago
Yuexiang (stock code 000819.SZ) from Yueyang forecasts a net loss of 26-32 million yuan in the first half of the year.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.